自身免疫性视网膜病变患者血浆抗视网膜自身抗体谱分析及诊断效能评估
这项多中心诊断评估研究纳入49例临床诊断的自身免疫性视网膜病变(AIR)患者、20例视网膜色素变性(RP)疾病对照和30例正常对照,用蛋白印迹法检测6种抗视网膜自身抗体(ARA)。AIR组抗锥杆同源盒/锥杆视网膜营养不良2抗体、抗热休克蛋白60抗体和抗醛缩酶C抗体阳性率分别为67.3%、40.8%和42.9%,高于对照组;ARA阳性数目越多,AIR诊断概率越高(比值比1.913)。作者认为ARA可作为AIR临床诊断的辅助工具。
要点
- AIR组抗锥杆同源盒/锥杆视网膜营养不良2抗体阳性率67.3%,抗热休克蛋白60抗体40.8%,抗醛缩酶C抗体42.9%,均高于RP和正常对照。
- 抗恢复蛋白抗体在3例(6.1%)AIR患者中检出,对照组均未检出,为特异性最高的ARA。
- ARA阳性数目增加与AIR诊断概率升高相关(比值比1.913,95%CI 1.456-2.785,P<.001)。
核心结论
- AIR组的ARA谱与RP组和正常对照组不同,阳性ARA数目越多提示AIR诊断可能性越高,ARA可作为AIR临床诊断的辅助工具。
研究设计与样本
- 多中心诊断评估研究,纳入49例临床诊断的AIR患者、20例视网膜色素变性(RP)疾病对照和30例正常对照,用蛋白印迹法检测血浆中6种ARA。
主要发现
- AIR组抗锥杆同源盒/锥杆视网膜营养不良2抗体阳性率为67.3%,高于RP和正常对照(P<.001)。
- AIR组抗热休克蛋白60抗体阳性率为40.8%,高于RP和正常对照(P<.001)。
- AIR组抗醛缩酶C抗体阳性率为42.9%,高于RP和正常对照(P=.007)。
- 抗恢复蛋白、抗α-烯醇化酶和抗碳酸酐酶II抗体在AIR组与对照组间无显著差异(P=.117、P=.774、P=.467)。
- 抗恢复蛋白抗体在3例(6.1%)AIR患者中检出,对照组均未检出;ARA阳性数目增加与AIR诊断概率升高相关(比值比1.913,95%CI 1.456-2.785,P<.001);光学相干断层扫描见光感受器破坏或视网膜电图见严重功能障碍时ARA阳性数目显著更高(P=.022和P=.029)。
关键数值与推荐
- 检测的6种ARA为恢复蛋白、α-烯醇化酶、碳酸酐酶II、热休克蛋白60、醛缩酶C和锥杆同源盒/锥杆视网膜营养不良2。
临床怎么用
- 作者认为ARA应作为AIR临床诊断的辅助工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate plasma antiretinal autoantibody (ARA) profiling and diagnostic efficacy for autoimmune retinopathy (AIR). DESIGN: A multicenter, diagnostic evaluation study. METHODS: Forty-nine patients with a clinical diagnosis of AIR, disease controls including 20 patients with retinitis pigmentosa (RP), and 30 normal controls were included. Plasma samples from patients were analyzed for the presence of 6 ARAs, including recoverin, α-enolase, carbonic anhydrase II, heat shock protein 60, aldolase C, and cone-rod homeobox/cone-rod retinal dystrophy 2 using western blotting. RESULTS: Autoantibody detection rates against cone-rod homeobox/cone-rod retinal dystrophy 2, heat shock protein 60, and aldolase C in AIR were 67.3%, 40.8%, and 42.9%, respectively, which were higher than those in RP and normal controls (P < .001, P < .001, and P = .007, respectively), but recoverin, α-enolase, and carbonic anhydrase II were not different from other control groups (P = .117, P = .774, and P = .467, respectively). Among ARAs, antirecoverin antibody was the most specific, as it was found in 3 (6.1%) patients with AIR and none of the control groups. As the number of detected ARAs increased, the probability of AIR increased (odds ratio: 1.913; P < .001; 95% confidence interval: 1.456-2.785). The positive number of ARAs was significantly higher when photoreceptor disruption was observed on optical coherence tomography, or severe dysfunction was observed in electroretinography (P = .022 and P = .029, respectively). CONCLUSIONS: The profiles of ARAs in the AIR group were different from those in the RP and normal controls. The higher number of positive ARAs suggests a higher possibility of AIR diagnosis. ARAs should be used as adjunct tools for the clinical diagnosis of AIR.
引用
- Bae SH, Hong HK, Lee JY, et al. Plasma Antiretinal Autoantibody Profiling and Diagnostic Efficacy in Patients With Autoimmune Retinopathy. Am J Ophthalmol. 2022. PMID: 35853491. doi:10.1016/j.ajo.2022.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。